홈 › 흑색종 › 워싱턴

워싱턴의 흑색종 임상 시험

흑색종 관련 연구 25개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴의 도시

공식 연구 텍스트(영어)

BostonGene and Exigent Genomic INsight Study

Northwest Medical Specialities, Puyallup

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06272864

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Swedish Cancer Institute Medical Oncology, Edmonds

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Swedish Cancer Institute - Edmonds Campus, Edmonds
Swedish Cancer Institute - Issaquah Campus, Issaquah
Kadlec Clinic Hematology and Oncology, Kennewick
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06246916

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Summit Cancer Center, Spokane

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06150664

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
외 20개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Kaiser Permanente Bellevue Medical Center, Bellevue
PeaceHealth Saint Joseph Medical Center, Bellingham
Swedish Cancer Institute-Edmonds, Edmonds
외 8개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0086, Seattle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07492680

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA09-0, Puyallup
USA07-0, Spokane

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06953089

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Wenatchee Valley Hospital and Clinics, Wenatchee

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 105, Spokane

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05914116

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

University of Washington Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1/2상

18세 ~ 99세 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06814496

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Northwest Medical Specialties, Tacoma

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Swedish Cancer Institute, Edmonds

피험자 모집 중3상

18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05727904

Pan-tumor MRD Study

Northwest Medical Specialties (NWMS), Tacoma

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center - Montlake, Seattle
Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale

피험자 모집 중3상

75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
외 15개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
외 1개

피험자 모집 중관찰 연구

25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06298734

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05098210

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Virginia Mason Medical Center, Seattle

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중2/3상

전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT05549297

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Seattle

피험자 모집 중관찰 연구

전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2024. 12. 19. 업데이트됨 · NCT06281678

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.